Share Name Share Symbol Market Type Share ISIN Share Description
Alkemy Capital Investments Plc LSE:ALK London Ordinary Share GB00BMD6C023 ORD GBP0.02
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  15.00 5.08% 310.00 280.00 310.00 307.00 280.00 295.00 72,274 16:35:13
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 0.0 -0.8 -19.9 - 22

Alkemy Capital Investments PLC Grant of Options

04/08/2022 8:00am

UK Regulatory (RNS & others)

Alkemy Capital Investments (LSE:ALK)
Historical Stock Chart

From Jun 2022 to Dec 2022

Click Here for more Alkemy Capital Investments Charts.


RNS Number : 8525U

Alkemy Capital Investments PLC

04 August 2022

4 August 2022

Alkemy Capital Investments Plc

Grant of Options

Alkemy Capital Investments plc ("Alkemy") (LSE: ALK) is pleased to announce that further to its announcement earlier today it has granted 590,000 share options at GBP1 per share, for a period of 5 years, to further align Directors and senior management with shareholders.

The share options will vest one-third immediately, one-third following completion of construction finance for train 1 of TVL's processing facility in Teesside, and one-third following commissioning of train 1 of TVL's processing facility.

In addition the share options will only be exerciseable if the share price of the Company is in excess of GBP5 per share for 10 consecutive days.

The grant of share options to directors is set out below:

                            Options   Exercise Price   Term 
 Paul Atherley (Chairman)   175,000   GBP1.00          5 years 
                           --------  ---------------  -------- 
 Sam Quinn (Director)       140,000   GBP1.00          5 years 
                           --------  ---------------  -------- 
 Helen Pein (Director)      75,000    GBP1.00          5 years 
                           --------  ---------------  -------- 

Further information

For further information, please visit the Company's website: or


Alkemy Capital Investments Plc    Tel: 0207 317 0636 
 Sam Quinn                
Buchanan                          Tel: 0207 466 5000 
 Bobby Morse/Abigail Gilchrist 
VSA Capital Limited               Tel: 0203 005 5000 
 Andrew Monk (corporate broking) 
 Andrew Raca (corporate finance) 
Shard Capital Partners LLP 
 Damon Heath                        Tel: 0207 186 9952 
 Isabella Pierre                    Tel: 0207 186 9927 


Alkemy is seeking to develop, construct and operate the world's leading independent and sustainable lithium hydroxide production facility.

Alkemy, through its wholly-owned subsidiary Tees Valley Lithium, has secured exclusivity to negotiate an option to lease over a 9.6ha brownfields site at the Wilton International Chemicals Park located in Teesside, a major UK Freeport.

Alkemy has completed a Class 4 Feasibility Study for its proposed lithium hydroxide facility to process feedstock imported from various sources to produce 96,000 tonnes of premium, low-carbon lithium hydroxide annually, representing around 15% of Europe's projected demand.

Forward Looking Statements

This news release contains forward--looking information. The statements are based on reasonable assumptions and expectations of management and Alkemy provides no assurance that actual events will meet management's expectations. In certain cases, forward--looking information may be identified by such terms as "anticipates", "believes", "could", "estimates", "expects", "may", "shall", "will", or "would". Although Alkemy believes the expectations expressed in such forward--looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those projected. In addition, factors that could cause actual events to differ materially from the forward-looking information stated herein include any factors which affect decisions as to how to develop the project, process the materials and exercise the options in respect of the lease, which may include changes in market conditions, changes in metal prices, general economic and political conditions, environmental risks, and community and non-governmental actions. Such factors will also affect whether Alkemy will ultimately receive the benefits anticipated pursuant to relevant agreements. This list is not exhaustive of the factors that may affect any of the forward--looking statements. These and other factors should be considered carefully and readers should not place undue reliance on forward-looking information.

The Notification of Dealing Form provided in accordance with the requirements of the Market Abuse Regulation in relation to the transaction listed above is set out below.

       Details of the person discharging managerial responsibilities 
  1     / person closely associated 
 a)    Name                                       1. Paul Atherley 
                                                   2. Sam Quinn 
                                                   3. Helen Pein 
      ------------------------------  ----------------------------------------------------- 
       Reason for the notification 
 a)    Position/status                            1. Chairman 
                                                   2. Director 
                                                   3. Director 
      ------------------------------  ----------------------------------------------------- 
 b)    Initial notification            Intial Notification 
      ------------------------------  ----------------------------------------------------- 
       Details of the issuer, emission allowance market participant, 
  3     auction platform, auctioneer or auction monitor 
 a)    Name                            Alkemy Capital Investments PLC 
      ------------------------------  ----------------------------------------------------- 
 b)    LEI                             213800NW5GVIRMXSRL48 
      ------------------------------  ----------------------------------------------------- 
       Details of the transaction(s): section to be repeated 
  4     for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
 a)    Description of the              Ordinary shares 
        financial instrument, 
        type of instrument 
       Identification code             GB00BMD6C023 
 b)    Nature of the transaction       Grant of Share Options subject to 
                                        vesting conditions and only be exerciseable 
                                        if the share price of the Company's 
                                        ordinary shares is in excess of GBP5 
                                        per share for 10 consecutive days. 
      ------------------------------  ----------------------------------------------------- 
 c)    Price(s) and volume(s) 
                                             ----------------------------  ------------ 
                                              Excersie Price(s)             Volume(s) 
                                             ----------------------------  ------------ 
                                                         1. 1.00            175,000 
                2. 1.00                                                      140,000 
                3. 1.00                                                      75,000 
   ----------------------------------------------------------------------  ------------ 
 d)    Aggregated information 
  - Aggregated volume             N/A 
  - Price                         GBP1.00 
 e)    Date of the transaction         03/08/2022 
      ------------------------------  ----------------------------------------------------- 
 f)    Place of the transaction        Outside a trading venue 
      ------------------------------  ----------------------------------------------------- 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

August 04, 2022 03:00 ET (07:00 GMT)

1 Year Alkemy Capital Investments Chart

1 Year Alkemy Capital Investments Chart

1 Month Alkemy Capital Investments Chart

1 Month Alkemy Capital Investments Chart
Your Recent History
Alkemy Cap..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20221209 23:09:05